Status:
UNKNOWN
pH, Hypoxia and Haemodialysis
Lead Sponsor:
Coventry University
Collaborating Sponsors:
University Hospitals Coventry and Warwickshire NHS Trust
Conditions:
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
18+ years
Brief Summary
End-stage renal disease typically requires haemodialysis to help replace kidney function. However, changes in oxygen uptake during haemodialysis have been linked to increased all-cause mortality. This...
Detailed Description
Alkalosis may explain multiple complications of HD treatment, most notably hypoxemia. Despite a strong rationale for these mechanisms, current consensus suggests ischaemia as the predominant catalyst ...
Eligibility Criteria
Inclusion
- On haemodialysis for at least 3 months.
- Haemodialysis 3 times per week.
- Age 18 years or older.
Exclusion
- Central venous catheter.
- Planned kidney transplant during the duration of study.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 29 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04501159
Start Date
May 1 2021
End Date
December 29 2021
Last Update
August 30 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UHCW
Coventry, Warwickshire, United Kingdom, CV1 3LN
2
University Hospital Coventry and Warwickshire
Coventry, West Midlands, United Kingdom, CV3